A Systematic, Patient-Centered Approach to Managing Advanced NSCLC
Hematology-Oncology
Curriculum:
A Systematic, Patient-Centered Approach to Managing Advanced NSCLC
A Systematic, Patient-Centered Approach to Managing Advanced NSCLC
Credits:
0.5 AMA PRA Category 1 Credit(s) ™
0.5 AMA PRA Category 1 Credit(s) ™
Launch Date:
April 27, 2017
April 27, 2017
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Oncology clinicians including physicians, nurse practitioners, and PAs
Relevant Terms:
Non-small cell lung cancer
Jamie E. Chaft, MD
Jamie E. Chaft, MD
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center
Assistant Professor
Weill Cornell Medical College
New York, New York
Bio
Jamie E. Chaft, MD, is assistant attending physician at Memorial Sloan Kettering Cancer Center. She completed her internal medicine internship and residency at Weill Cornell Medical College at New York-Presbyterian Hospital, and went on to complete her medical oncology fellowship at Memorial Sloan Kettering Cancer Center. She is a member of the Thoracic Oncology Service, with a focus on clinical research and treatment of patients with thoracic malignancies.Serving as a principal investigator, Dr Chaft has participated in and led many research studies. Her clinical research focus includes multimodality therapy for the treatment of early stage lung cancer and the use of immunotherapies as treatment of patients with lung cancers. Her studies aim to utilize drugs that show promise in metastatic lung cancers in patients with potentially curable disease. She has published on the use of bevacizumab and gefitinib in early stage lung cancers, and is the study chair of the National Cancer Institute-sponsored study of adjuvant nivolumab after curative lung cancer resection.
| 1. | Select appropriate evidence-based and personalized treatment for patients with newly diagnosed advanced NSCLC based upon tumor features, such as histology, molecular mutations, PD-L1 expression, and guideline recommendations | 2. | Implement second-line or subsequent lines of therapy taking into account prior therapy, tumor characteristics, and guideline recommendations |
| 3. | Encourage and educate patients with advanced NSCLC to participate in treatment decisions by implementing effective shared decision-making strategies |
| 1. | Select appropriate evidence-based and personalized treatment for patients with newly diagnosed advanced NSCLC based upon tumor features, such as histology, molecular mutations, PD-L1 expression, and guideline recommendations |
| 2. | Implement second-line or subsequent lines of therapy taking into account prior therapy, tumor characteristics, and guideline recommendations |
| 3. | Encourage and educate patients with advanced NSCLC to participate in treatment decisions by implementing effective shared decision-making strategies |
PHYSICIAN CONTINUING MEDICAL EDUCATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Jamie E. Chaft, MD, has affiliations with Astra Zeneca, Bristol-Myers Squibb (BMS), Genentech, and Merck (Consulting Fees); and Astra Zeneca, BMS, and Genentech (Contracted Research).
RMEI Medical Education, LLC
- Anne Jacobson, CHCP, has no affiliations with commercial interests to disclose.
- Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
- Leslie Treff, JD, has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, have nothing to disclose.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Estimated time to complete: 30 minutes
Media: Internet
Media: Internet
COMMERCIAL SUPPORT
This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC. This activity is supported by an independent medical educational grant from Genentech and Lilly.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 0.5 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
